muzolimine has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlit, P; Gretz, N; Maibach, EA; Pohlmann-Eden, B | 1 |
| Berlit, P; Gretz, N; Holle, A; Kaschel, H; Pohlmann-Eden, B | 1 |
2 other study(ies) available for muzolimine and Demyelinating Diseases
| Article | Year |
|---|---|
Muzolimine-induced severe neuromyeloencephalopathy: report of seven cases.
Topics: Adult; Aged; Demyelinating Diseases; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Muscular Atrophy; Muzolimine; Peripheral Nerves; Peripheral Nervous System Diseases; Pyramidal Tracts; Spinal Cord; Spinal Cord Diseases | 1991 |
[Neuromyeloencephalopathy caused by high-dose muzolimine medication in patients with renal failure].
Topics: Adult; Aged; Central Nervous System Diseases; Demyelinating Diseases; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Evoked Potentials; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Muzolimine; Neural Pathways; Neuromuscular Diseases; Peripheral Nervous System Diseases; Pyrazoles; Spinal Nerve Roots; Synaptic Transmission | 1990 |